- Home
- CMU vs FBRX Comparison
CMU vs FBRX Comparison
Compare CMU & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMU
- FBRX
- Stock Information
- Founded
- CMU 1987
- FBRX N/A
- Country
- CMU United States
- FBRX United States
- Employees
- CMU N/A
- FBRX N/A
- Industry
- CMU Investment Managers
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- CMU Finance
- FBRX Health Care
- Exchange
- CMU Nasdaq
- FBRX Nasdaq
- Market Cap
- CMU 85.1M
- FBRX 69.7M
- IPO Year
- CMU N/A
- FBRX N/A
- Fundamental
- Price
- CMU $3.27
- FBRX $9.86
- Analyst Decision
- CMU
- FBRX Strong Buy
- Analyst Count
- CMU 0
- FBRX 2
- Target Price
- CMU N/A
- FBRX $61.00
- AVG Volume (30 Days)
- CMU 82.4K
- FBRX 187.7K
- Earning Date
- CMU 01-01-0001
- FBRX 08-13-2025
- Dividend Yield
- CMU 4.08%
- FBRX N/A
- EPS Growth
- CMU N/A
- FBRX N/A
- EPS
- CMU 0.07
- FBRX N/A
- Revenue
- CMU N/A
- FBRX N/A
- Revenue This Year
- CMU N/A
- FBRX N/A
- Revenue Next Year
- CMU N/A
- FBRX N/A
- P/E Ratio
- CMU $47.57
- FBRX N/A
- Revenue Growth
- CMU N/A
- FBRX N/A
- 52 Week Low
- CMU $2.78
- FBRX $4.11
- 52 Week High
- CMU $3.38
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- CMU 33.07
- FBRX 44.73
- Support Level
- CMU $3.27
- FBRX $10.15
- Resistance Level
- CMU $3.34
- FBRX $13.20
- Average True Range (ATR)
- CMU 0.02
- FBRX 1.89
- MACD
- CMU -0.01
- FBRX -0.38
- Stochastic Oscillator
- CMU 10.00
- FBRX 4.72
About CMU MFS Municipal Income Trust
Mfs High Yield Municipal Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes. The company invest various top Healthcare companies, Airport, Universities (Secondary Schools), Universities (Dormitories), and many more, out of maximum revenue is gained from Healthcare Hospitals and Long Term Care.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).